Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Champions Oncology (CSBR) Receivables - Net (2016 - 2026)

Champions Oncology has reported Receivables - Net over the past 16 years, most recently at $12.1 million for Q1 2026.

  • For Q1 2026, Receivables - Net fell 23.54% year-over-year to $12.1 million; the TTM value through Jan 2026 reached $12.1 million, down 23.54%, while the annual FY2025 figure was $11.2 million, 17.61% up from the prior year.
  • Receivables - Net for Q1 2026 was $12.1 million at Champions Oncology, up from $11.5 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $15.8 million in Q1 2025 and troughed at $7.7 million in Q4 2023.
  • A 5-year average of $9.8 million and a median of $9.4 million in 2022 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: surged 156.92% in 2022 and later dropped 23.54% in 2026.
  • Year by year, Receivables - Net stood at $9.0 million in 2022, then dropped by 14.44% to $7.7 million in 2023, then surged by 35.97% to $10.5 million in 2024, then increased by 10.21% to $11.5 million in 2025, then increased by 4.58% to $12.1 million in 2026.
  • Business Quant data shows Receivables - Net for CSBR at $12.1 million in Q1 2026, $11.5 million in Q4 2025, and $10.5 million in Q3 2025.